[1] Pooh R T,Ngan H,Lo C M,et al.Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence [J].Surg Oncol,2000,73:109-114.
[2] Marelli L.Shusang V,Buscombe J R,et al.Transarterial injection of 131I-lipiedol, compared with chemoembolization,in the treatment of unresectable hepatacellular cancer [J].Nucl Med, 2009, 50:871-877.
[3] Kim Q,Kim J H,Park I S,et al.Reappraisal of repeated transarterial ehemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion [J].Gastroenterol Hepatol, 2009, 24:806-814.
[4] Eisenhauer E A,11lem∞P,Bogaerts J,et al.New response evaluation criteria in solid tumours-revised RECIST guideline (version 1.1) [J].Gan To Kagaku Ryoho, 2009, 36(13): 2495-2501.
[5] 赵广生,张跃伟,刘 影,等. 新型明胶海绵微粒TACE治疗原发性肝癌术后致肝脓肿三例及文献复习[J]. 介入放射学杂志, 2013, 5: 415-417.
[6] 高 峰,张雪娜,陈茂粮,等. 原发性肝癌TACE术后预防性抗生素应用价值研究[J]. 介入放射学杂志, 2013, 22(2): 151-153.
[7] 李申生,顾海雁,红摇伟,等. 上海市徐汇区原发性肝癌患者随访队列生存分析[J]. 中国慢性病预防与控制, 2008, 16(5): 468-470.
[8] 吴孟超. 肝癌外科治疗的近期进展[J]. 中国普外基础与临床杂志, 2006, 13(2): 125-128.
[9] 程红岩,徐 雯,徐爱民,等. 肝动脉插管化疗栓塞在预防肝癌术后复发中的应用价值[J]. 中华肿瘤杂志,2005,27(10):626-628.